Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease



Status:Recruiting
Conditions:Parkinsons Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 65
Updated:11/16/2018
Start Date:March 30, 2017
End Date:April 2019
Contact:Sun Pharma Advanced research company Limited
Email:clinical.trials@sparcmail.com
Phone:+91 22 6645 5645

Use our guide to learn which trials are right for you!

A Double-blind, Placebo-controlled Study to Determine Safety, Tolerability, Pharmacokinetic of K0706.

This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease


Inclusion Criteria:

1. Willing and able to give written, and dated, informed consent (or legally acceptable
representative/impartial witness when applicable) and is available for the entire
study

2. Willing and able to comply with the scheduled visits, treatment plan, laboratory
testing, study procedures, and restrictions (in the Investigator's opinion), and be
accessible for follow-up

3. Male or female aged 18 to 65 years (both inclusive)

4. Diagnosed with Parkinson's disease

Exclusion Criteria:

1. Clinical diagnosis of genetic form of Parkinson's disease, or drug-induced
parkinsonism

2. Diagnosis of Parkinson's disease Dementia (probable, possible)

3. Presence of severe dyskinesias

4. History of brain surgery for Parkinson's disease
We found this trial at
5
sites
Long Beach, California
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
DeLand, Florida 32720
?
mi
from
DeLand, FL
Click here to add this to my saved trials
Orlando, Florida
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Panorama City, California 91402
?
mi
from
Panorama City, CA
Click here to add this to my saved trials
Raleigh, North Carolina 27612
?
mi
from
Raleigh, NC
Click here to add this to my saved trials